Skånes Onkologiska Klinik, Universitetssjukhuset

Lund, Sweden
Medical clinic in Lund
Lasarettsgatan 23 A, 222 41 Lund

About Skånes Onkologiska Klinik, Universitetssjukhuset


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Skånes Onkologiska Klinik, Universitetssjukhuset


During the past decade, Skånes Onkologiska Klinik, Universitetssjukhuset conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
1999-05-01
2017-07-19
Completed
475
Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure.
2002-09-01
2004-12-01
Completed
600
Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer
2005-03-01
Completed
623
Study to Compare the Efficacy and Safety of CC-5013 vs. Placebo in Subjects With Metastatic Malignant Melanoma.
2002-10-01
2005-07-15
Completed
274
Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
2003-11-03
2025-12-01
Active, not recruiting
2,672
S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
2003-10-01
2016-09-01
Completed
257
Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
2005-05-01
Completed
520
Carboplatin in Treating Patients With Stage IC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
2004-03-01
2010-07-01
Completed
1,300

Rows per page:

1–100 of 176

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Skånes Onkologiska Klinik, Universitetssjukhuset" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Clovis Oncology, Inc." with 1 trials sponsored, "Millennium Pharmaceuticals, Inc." with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "Puma Biotechnology, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Skånes Onkologiska Klinik, Universitetssjukhuset" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator, "Foundation Medicine" with 1 trials as a collaborator, "Gynecologic Oncology Group" with 1 trials as a collaborator and "Johnson & Johnson Pharmaceutical Research & Development, L.L.C." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Skånes Onkologiska Klinik, Universitetssjukhuset


According to Clinical.Site data, the most researched conditions in "Skånes Onkologiska Klinik, Universitetssjukhuset" are "Basal Cell Carcinoma" (1 trials), "Breast Cancer" (1 trials), "Complete Response" (1 trials), "Epithelial Ovarian Cancer" (1 trials) and "FIGO Stage III-IV" (1 trials). Many other conditions were trialed in "Skånes Onkologiska Klinik, Universitetssjukhuset" in a lesser frequency.

Clinical Trials Intervention Types at Skånes Onkologiska Klinik, Universitetssjukhuset


Most popular intervention types in "Skånes Onkologiska Klinik, Universitetssjukhuset" are "Drug" (6 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Bortezomib + Rituximab" (1 trials), "Nivolumab" (1 trials), "Placebo" (1 trials), "Placebo IV Infusion" (1 trials) and "Placebo Oral Tablet" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Skånes Onkologiska Klinik, Universitetssjukhuset


The vast majority of trials in "Skånes Onkologiska Klinik, Universitetssjukhuset" are 4 trials for "All" genders and 2 trials for "Female" genders.

Clinical Trials Status at Skånes Onkologiska Klinik, Universitetssjukhuset


Currently, there are NaN active trials in "Skånes Onkologiska Klinik, Universitetssjukhuset". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Skånes Onkologiska Klinik, Universitetssjukhuset, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Skånes Onkologiska Klinik, Universitetssjukhuset, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status